top of page

News Archives

PRESS RELEASES

July 12, 2018 - Ceres Nanosciences’ Point-of-Care Nanotrap® Lyme Antigen Test System Granted Breakthrough Device Designation by U.S. Food and Drug Administration

May 31, 2018 - Ceres Nanosciences reaches product development milestone for point-of-care Lyme disease test and closes on an additional $5.5M of Series A funding  

December 12, 2017 - Ceres announces major expansion with new Nanotrap® particle manufacturing site in Northern Virginia 

September 28, 2017 - Ceres part of team receiving $4.25MM from the DOD to develop a universal surveillance platform for infectious disease outbreaks

February 22, 2017 - Ceres receives $750K award from DARPA to adapt Nanotrap® platform to detect Zika and other febrile illnesses

 

February 2, 2017 - Ceres announces $9MM Series A investment round with initial $3MM investment from GreyBird Ventures

 

July 6, 2016 - Ceres receives $980K award from DARPA/US Department of Defense to adapt Nanotrap® to capture immune markers from non-invasive samples

November 10, 2015 - Ceres Nanosciences announces the publication of pioneering clinical study to develop urine based Lyme Antigen Test. 

 

June 29, 2015 - Ceres receives $746K from the Bill & Melinda Gates Foundation to use the Nanotrap® to develop a highly sensitive, rapid test for Tuberculosis in urine

 

March 11, 2015 - Ceres partners with Johns Hopkins to evaluate Nanotrap® saliva test for Malaria

 

December 2, 2014 - Ceres receives $430K in funding for Ebola test development program from the Bill & Melinda Gates Foundation. Will use Nanotrap® to screen for Ebola Virus in saliva at earliest stages of infection

 

July 10, 2014 - TGen and Ceres Nanosciences announce collaboration to develop high-throughput Nanotrap® enrichment methods for Mass Spectrometry

 

July 10, 2013 - Ceres Nanosciences awarded Phase II funding to develop Nanotrap® enhanced detection platform for Rift Valley Fever Virus 

 

May 30, 2013 - Ceres Nanosciences awarded funding from Virginia Commercialization program to further development of Nanotrap® Universal Sample Collection Toolset 

 

September 9, 2012 - Ceres Nanosciences awarded DARPA Phase II SBIR to develop Nanotrap® Universal Sample Collection Toolset 

 

May 23, 2011 - Ceres Nanosciences announces issuance of two Nanotrap® patents 

 

February 22, 2011 - Ceres Nanosciences awarded 250K to develop Nanotrap® based universal sample preparation tool for Rift Valley Fever Virus 

 

April 13, 2010 - Ceres Nanosciences completes USADA funded clinical study to measure HGH in urine and establish initial human baseline levels 

 

April 22, 2009 - Ceres Nanosciences and SAIC-Frederick Collaborate On Cancer Steroid Hormone Studies using Nanotrap® platform

 

March 1, 2009 - Ceres Nanosciences and USADA Join To Advance Research Aimed at Developing an HGH Urine-Based Test for Benefit of Clean Sport 

 

July 21, 2008 - Ceres Nanosciences to Develop Nanotechnology Products for Health Care, Industry and Government Applications 

NEWS PUBLICATIONS

August 7, 2018  - Hope for Lyme disease victims: Researchers race to develop new tests — and a vaccine

CNBC

August 1, 2018  - Comstock: Putting a Bullseye on Lyme Disease

Loudoun Now

July 20, 2018  - Manassas firm gets step closer to new urine test for Lyme disease

The Washington Business Journal

May 25, 2018  - Episode 43: If You Build It…We Will Grow

The Project Podcast: Inside Corporate Location Decisions

March 12, 2018 Potential New Clinical Laboratory Urine Test for TB Could Speed Up Diagnosis and Treatment of Disease That Kills 1.7 Million People Each Year

Dark Daily

January 1, 2018 Fast, Cheap Testing for Tuberculosis? Soon It May Be Possible

New York Times

September 28, 2017 DoD funds research to monitor infectious disease

STAT News

February 7, 2017  - A technology backed by Bill Gates may revolutionize diagnostics for Lyme disease

CNBC

October 7, 2016  - Ceres CEO, Ross Dunlap on the Science Behind Ceres Nanosciences (VIDEO)

ACG National Capital - Annual Growth Conference

 

September 22, 2016  - Ceres receives award for being one of the Washington area's most innovative companies

Washington Business Journal

 

June 1, 2016  - Early-Detection Urine Test Is Effective for Lyme Disease

Labmedica 

 

February 12, 2016  - Researchers discover early Lyme Disease detection

WJLA ABC7 News Report

 

November 24, 2015  - George Mason University spinoff plans to disrupt the diagnostics market

Washington Business Journal

 

November 20, 2015 -  Ceres Wins $500K From VBHRC to Further Develop Lyme Dx; Begins Offering Test Nationwide

GenomeWeb

 

May 12, 2015 - New Lyme disease test in clinical phase at Northern Virginia lab

Loudoun Times Mirror

 

March 11, 2015 - Johns Hopkins Researchers to Evaluate Malaria Saliva Test

Global Biodefense

 

July 29, 2013 - Researcher Returns to Africa with New Way to "Trap" Deadly Virus

George Mason University

 

July 15, 2013 - Taking the mystery out of Lyme disease

The Fairfax Times 

 

September 15, 2011 - Ceres Nanosciences' scientist awarded Popular Science's "Brilliant 10" award for Nanotrap® work

Popular Science 

 

February 2, 2010 - Shimadzu, Ceres Nanosciences And Nonlinear Dynamics Introduce Nanotrap® Biomarker Discovery Platform

Biocompare 

 

April 22, 2009 - Ceres Nanosciences and SAIC-Frederick Collaborate On Cancer Steroid Hormone Studies

Nanowerk

 

February 26, 2009 - USADA will help fund further study of urine test for HGH

USA Today

 

December 17, 2008 - Pioneering mind-set at George Mason produces new HGH test

USA Today

 

December 20, 2008 - Urine test for HGH gets boost from scientific journal

USA Today

 

November 17, 2008  - Professors, Entrepreneurs Seek Synergies

The Washington Post

 

July 23, 2008 - Scientists say breakthrough urine test for HGH developed

USA Today

 

July 18, 2008 - GMU spinoff hopes nanotech product is a home run

Washington Business Journal

 

February 27, 2008 - In a Va. Lab, Forging Links To Speed Cancer Advances

The Washington Post

bottom of page